Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Analyst Ratings for Genmab

Within the last quarter, Genmab (NASDAQ:GMAB) has observed the following analyst ratings:

Benzinga

Actelis Networks, Inc. IPOs Tomorrow, Here's What You Need To Know

Actelis Networks, Inc. (NASDAQ:ASNS) IPO will take place May, 13 on the NASDAQ exchange under the ticker ASNS. The company is offering shares at an expected price between $4.00 and $6.00 per share with an insider lock-up period of 180 days ending on November 09, 2022.

Benzinga

Krispy Kreme's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Krispy Kreme (NASDAQ:DNUT) earned $6.46 million, a 50.78% increase from the preceding quarter. Krispy Kreme also posted a total of $372.53 million in sales, a 0.52% increase since Q4.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What's Going On With Bitcoin- And Ethereum-Related Stock Marqeta?

Marqeta Inc (NASDAQ: MQ) shares are trading higher by 20.4% at $7.98. The company reported first-quarter earnings results during Wednesday’s after-hours session. The stock was halted for volatility at 10:12 a.m. EDT.

Benzinga

MicroStrategy Earnings Perspective: Return On Capital Employed

MicroStrategy (NASDAQ:MSTR) brought in sales totaling $119.28 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 45.32%, resulting in a loss of $130.75 million.

Benzinga

PTC Therapeutics's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q1, PTC Therapeutics's (NASDAQ:PTCT) reported sales totaled $148.74 million. Despite a 11.54% increase in earnings, the company posted a loss of $126.73 million.

Benzinga

Mid-Morning Market Update: Markets Open Lower; U.S. Producer Prices Rise 0.5% In April

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Thursday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Huron Consulting Group's Return On Invested Capital

According to Benzinga Pro data Huron Consulting Group (NASDAQ:HURN) posted a 13.54% decrease in earnings from Q4. Sales, however, increased by 4.73% over the previous quarter to $260.05 million.

Benzinga

Verisk Analytics's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Verisk Analytics (NASDAQ:VRSK) earned $505.80 million, a 256.7% increase from the preceding quarter. Verisk Analytics also posted a total of $775.50 million in sales, a 1.24% increase since Q4.

Benzinga

Denny's's Return on Invested Capital Insights

Pulled from Benzinga Pro data, Denny's (NASDAQ:DENN) posted Q1 earnings of $21.86 million, an increase from Q4 of 49.71%. Sales dropped to $103.11 million, a 4.21% decrease between quarters.

Benzinga

Looking Into Infinera's Return On Capital Employed

Infinera (NASDAQ:INFN) brought in sales totaling $338.87 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 26.56%, resulting in a loss of $41.85 million.

Benzinga

Apollo Endosurgery's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q1, Apollo Endosurgery's (NASDAQ:APEN) reported sales totaled $16.66 million. Despite a 19.14% increase in earnings, the company posted a loss of $8.41 million.

Benzinga

CytoSorbents's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q1, CytoSorbents's (NASDAQ:CTSO) reported sales totaled $8.69 million. Despite a 3.66% increase in earnings, the company posted a loss of $8.97 million.

Benzinga

What 4 Analyst Ratings Have To Say About Enanta Pharmaceuticals

Over the past 3 months, 4 analysts have published their opinion on Enanta Pharmaceuticals (NASDAQ:ENTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Peering Into Coinbase Global's Recent Short Interest

Coinbase Global's (NASDAQ:COIN) short percent of float has risen 17.45% since its last report. The company recently reported that it has 7.28 million shares sold short, which is 4.98% of all regular shares that are available for trading.

Benzinga

Data Is The New Oil? Not Yet! Saudi Aramco Surpasses Apple To Become Most Valuable Company

Saudi Aramco has beaten Apple Inc (NASDAQ: AAPL) to become the most valuable company,

Benzinga

CEO Of 'India's Robinhood' Echoes Coinbase's Warning: Crypto Exchanges Carry A Risk

Indian financial services firm Zerodha's co-founder and CEO Nithin Kamath sounded the alarm for crypto investors as the U.S. cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN) shot a bankruptcy-related warning.

Benzinga

Where Food Comes From: Q1 Earnings Insights

Where Food Comes From (NASDAQ:WFCF) reported its Q1 earnings results on Thursday, May 12, 2022 at 09:30 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

4 Analysts Have This to Say About Atlantica Sustainable

Analysts have provided the following ratings for Atlantica Sustainable (NASDAQ:AY) within the last quarter:

Benzinga

RVL Pharmaceuticals: Q1 Earnings Insights

RVL Pharmaceuticals (NASDAQ:RVLP) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

Benzinga

Alibaba And Other Chinese Stock Investors Remain Cautious Over China's Political Body Forum With Leading Firms

China’s top political advisory body looks to host a forum next week with some of the nation’s largest private-sector firms, including Baidu, Inc (NASDAQ:BIDU), Bloomberg reports. While the conference focused on developing China’s digital economy, investors will likely watch for a possible wind-down of its year-long crackdown on the tech sector after a…

Benzinga

Where SciPlay Stands With Analysts

Within the last quarter, SciPlay (NASDAQ:SCPL) has observed the following analyst ratings:

Benzinga

Expert Ratings for Prelude Therapeutics

Prelude Therapeutics (NASDAQ:PRLD) has observed the following analyst ratings within the last quarter:

Benzinga

Carrols Restaurant Reports Mixed Q1 Results

Carrols Restaurant Group Inc (NASDAQ:TAST) reported first-quarter FY22 sales growth of 2.4% year-on-year to $399.48 million, missing the consensus of $402.37 million. Comparable restaurant sales for Burger King restaurants increased 1.6%, and Popeyes restaurants increased 2.2%. Operating expenses rose 6.7% Y/Y to $419.3 million. The operating loss for the quarter was $(19.8) million…

1 … 508 509 510 511

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.